Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00795418
Show Display Options
Rank Status Study
1 Completed Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients
Condition: Alzheimer's Disease
Interventions: Biological: Placebo;   Biological: CAD106

Indicates status has not been verified in more than two years